Feynman nano (unnamed Infection-resistant materials) definitely ticks both the ambition, problem and market boxes. There is currently a ~$30 billion market for catheters, production at scale of nano-structures is currently unsolved. Combined with the current growth of antibiotic resistant golden staph infections, they would seem to be poised for market dominance if successful.
No comments yet.